<DOC>
	<DOC>NCT01106703</DOC>
	<brief_summary>The aim of this study was to evaluate the efficacy of PG102 at lowering levels of total IgE in asymptomatic subjects with atopy.</brief_summary>
	<brief_title>The Effects of PG102, a Water Soluble Extract From Actinidia Arguta, on Serum Total IgE Levels</brief_title>
	<detailed_description />
	<criteria>subjects who have atopy but no allergyrelated symptoms subjects with total IgE levels of 300IU/ml or more acquisition of written informed consent prior to commencement of study no serious clinical symptoms and normal laboratory test results; in case of abnormal finding, subjects whose conditions are not deemed severe from the judgement of investigators individuals with normal levels of total serum IgE ue of one or more allergic drugs serious clinical conditions (such as malignancies, severe cardiovascular disease etc.) serious mental disorder pregnant woman or woman of childbearing potential within 3 months subjects who participated in other clinical trials in the past 6months individuals who have a plan to participate in another clinical trials during this trial subjects with a history of kiwi allergy subjects whose conditions are inappropriate by investigators</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>atopy, IgE</keyword>
</DOC>